Non Valvular AF ,AF Clinical Trial
Official title:
Demographic Outcomes, and Health Care Resources in Newly Diagnosed Non Valvular AF Patients
1. To describe the patterns of care of newly diagnosed patients with NVAF vs VAF in the
first-line, second-line and beyond second line setting, including, treatment plan,
regimen, dosing, duration of treatment, and reason for interruption and termination
along with treatment switching at any point of treatment, regardless if the patients are
considered of first line, second line or further within the treatments.
2. To describe the clinical outcomes (stroke/systemic embolism, bleeding complications, as
well as cause-specific and all-cause mortality) with NVAF vs VAF.
3. To describe the values and distribution of International normalized ratio (INR) in
patients who received VKAs and to assess the influence of Time in therapeutic range
(TTR) and INR history on clinical outcomes (stroke/systemic embolism, bleeding
complications) with NVAF vs VAF.
4. To evaluate AF-related healthcare resource utilization and direct costs associated with
the management of AF patients with NVAF vs VAF.
and To describe the baseline clinical and demographic characteristics as well as risk factors
among patients newly diagnosed with NVAF versus VAF.
n/a